Ritesh Agarwal

About Ritesh Agarwal

Ritesh Agarwal, With an exceptional h-index of 78 and a recent h-index of 55 (since 2020), a distinguished researcher at Post Graduate Institute of Medical Education and Research, specializes in the field of Allergic Bronchopulmonary Aspergillosis, Fungal diseases, Asthma, Bronchiectasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

A multicentre, double-blind, placebo-controlled randomized trial of Mycobacterium w in critically ill patients with COVID-19 (ARMY-2)

Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses

Sensitivity and specificity of LDBio Aspergillus ICT lateral flow assay for diagnosing allergic bronchopulmonary aspergillosis in adult asthmatics

Aerosolized Antifungals for the Treatment of Pulmonary Fungal Diseases

Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease

Incidence and prevalence of chronic pulmonary aspergillosis in patients with post‐tuberculosis lung abnormality: Results from a community survey in North India

Pleural effusion guidelines from ICS and NCCP Section 1: Basic principles, laboratory tests and pleural procedures

Polymorphisms in Innate and Adaptive Immune Genes in Subjects with Allergic Bronchopulmonary Aspergillosis Complicating Asthma

Ritesh Agarwal Information

University

Position

Professor of Pulmonary Medicine Chandigarh

Citations(all)

23450

Citations(since 2020)

12711

Cited By

15002

hIndex(all)

78

hIndex(since 2020)

55

i10Index(all)

352

i10Index(since 2020)

270

Email

University Profile Page

Post Graduate Institute of Medical Education and Research

Google Scholar

View Google Scholar Profile

Ritesh Agarwal Skills & Research Interests

Allergic Bronchopulmonary Aspergillosis

Fungal diseases

Asthma

Bronchiectasis

Top articles of Ritesh Agarwal

Title

Journal

Author(s)

Publication Date

A multicentre, double-blind, placebo-controlled randomized trial of Mycobacterium w in critically ill patients with COVID-19 (ARMY-2)

Lung India

Inderpaul S Sehgal

Ritesh Agarwal

Atul Jindal

Md Sabah Siddiqui

Anant Mohan

...

2024/3/1

Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses

European Respiratory Journal

Ritesh Agarwal

Inderpaul Singh Sehgal

Valliappan Muthu

David W Denning

Arunaloke Chakrabarti

...

2024/4/1

Sensitivity and specificity of LDBio Aspergillus ICT lateral flow assay for diagnosing allergic bronchopulmonary aspergillosis in adult asthmatics

Mycoses

Inderpaul Singh Sehgal

Valliappan Muthu

Sahajal Dhooria

Kuruswamy Thurai Prasad

Shivaprakash M Rudramurthy

...

2024/2

Aerosolized Antifungals for the Treatment of Pulmonary Fungal Diseases

Valliappan Muthu

Inderpaul Singh Sehgal

Ritesh Agarwal

2024/4/1

Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease

Matthias J Neuböck

Gunar Günther

Aleksandra Barac

Jesper R Davidsen

Christian B Laursen

...

2024/1/9

Incidence and prevalence of chronic pulmonary aspergillosis in patients with post‐tuberculosis lung abnormality: Results from a community survey in North India

Mycoses

Kathirvel Soundappan

Inderpaul Singh Sehgal

Nidhi Prabhakar

Samriti Rana

Rajesh Raju

...

2024/3

Pleural effusion guidelines from ICS and NCCP Section 1: Basic principles, laboratory tests and pleural procedures

Lung India

Devasahayam J Christopher

Richa Gupta

Balamugesh Thangakunam

Jefferson Daniel

Surinder K Jindal

...

2024/5/1

Polymorphisms in Innate and Adaptive Immune Genes in Subjects with Allergic Bronchopulmonary Aspergillosis Complicating Asthma

Mycopathologia

Rimjhim Kanaujia

Amit Arora

Arunaloke Chakrabarti

Shivaprakash M Rudramurthy

Ritesh Agarwal

2024/4

A Case of ABPA-CPA Overlap: Fallitur Identitatis…

Internal Medicine

Inderpaul Singh Sehgal

Ritesh Agarwal

2024

Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India

Clinical Microbiology and Infection

Valliappan Muthu

Ritesh Agarwal

Shivaprakash Mandya Rudramurthy

Deepak Thangaraju

Manoj Radhakishan Shevkani

...

2024/3/1

Isolated tracheal mucormycosis in diabetes mellitus and bronchoscopic management

Lung India

Vikram Damaraju

Ritesh Agarwal

Nidhi Prabhakar

Amanjit Bal

Shivaprakash M Rudramurthy

...

2024/5/1

Pulmonary artery aneurysms: mycotic or mycobacterial?

Clinical Infectious Diseases

Valliappan Muthu

Ritesh Agarwal

2024/3/15

Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases

Edwin Nuwagira

Joseph Baruch Baluku

David B Meya

Lisa Liang Philpotts

Mark J Siedner

...

2022/8/1

Reply: A suggested classification of disease behaviour and treatment response in sarcoidosis trials

European Respiratory Journal

Sahajal Dhooria

Inderpaul Singh Sehgal

Ritesh Agarwal

2024/1/1

A 61-year-old lady with acute-onset wheeze and hypoxemia

Lung India

Sandeep Kumar

Arun Sharma

Kuruswamy Thurai Prasad

Inderpaul S Sehgal

Sahajal Dhooria

...

2024/3/1

Computed tomography findings of COVID-19-associated pulmonary mucormycosis: Data from a multicenter retrospective study (Mucovi2), India

Lung India

Valliappan Muthu

Ritesh Agarwal

Shivaprakash Mandya Rudramurthy

Deepak Thangaraju

Manoj Radhakishan Shevkani

...

2024/5/1

Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells

Mycoses

Manpreet Dhaliwal

Valliappan Muthu

Arunima Sharma

Khem Raj

Shivaprakash M Rudramurthy

...

2024/1

Association of MUC5B promoter polymorphism with interstitial lung changes after COVID-19: A preliminary observation

Indian Journal of Medical Research

Sahajal Dhooria

Amanjit Bal

Riya Sharma

Nidhi Prabhakar

Siddhant Arora

...

2024/2/9

Aspergillus infection is an important complication of post-TB bronchiectasis

The International Journal of Tuberculosis and Lung Disease

IS Sehgal

V Muthu

R Agarwal

2023/1/1

Efficacy and safety of doxycycline versus iodopovidone for pleurodesis through an intercostal tube in malignant pleural effusions: a randomized trial

Supportive Care in Cancer

Vikram Damaraju

Inderpaul Singh Sehgal

Valliappan Muthu

Kuruswamy Thurai Prasad

Sahajal Dhooria

...

2023/8

See List of Professors in Ritesh Agarwal University(Post Graduate Institute of Medical Education and Research)

Co-Authors

H-index: 74
Ashutosh N. Aggarwal

Ashutosh N. Aggarwal

Post Graduate Institute of Medical Education and Research

H-index: 40
Inderpaul Singh Sehgal

Inderpaul Singh Sehgal

Post Graduate Institute of Medical Education and Research

H-index: 23
Kuruswamy Thurai Prasad

Kuruswamy Thurai Prasad

Post Graduate Institute of Medical Education and Research

academic-engine